India’s Panacea Biotec partners with US firm to make Covid-19 vaccine
Team Udayavani, Jun 12, 2020, 12:05 PM IST
Indian biotech firm Panacea Biotec Ltd will partner with U.S.based Refana Inc to make a potential vaccine for Covid-19
Under the partnership, Panacea Biotec will be responsible for product development and commercial manufacturing of an inactivated virus-based vaccine
The collaboration aims to make more than 500 million doses of the vaccine candidate, with over 40 million doses expected to be available early next year.
The company said that after the CGMP process, the first phase of the human trial will be held by October and they will be able to conduct the third phase of the trial on a large scale.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Snatcher lands in police net in Delhi, AI tech helps reveal identity
AI Meets Health: The Rise of Smart Fitness Solutions
Power Up by Powering Down: 10 Energy-Saving Tips for Every Home
Multi-lingual AI chatbot to assist visitors during Maha Kumbh Mela 2025
ISRO carries out ‘well deck’ recovery trial of Gaganyaan
MUST WATCH
Latest Additions
Bhadravathi: Seven injured in boiler explosion at rice mill
Strict provisions of law for women’s welfare; marriage not commercial venture: SC
Allegation of abuse against K’taka Minister Laxmi: BJP leader C T Ravi booked, taken into custody
Gadag: 2-yo girl dies after being run over by water tanker
Mangaluru Traffic Advisory: Netravathi Bridge repair work to affect vehicle movement
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.